Author

T Omland

Observed names: Omland T, Omland, Torbjམrn, T M Omland, T O Omland, T O Torbjoern Omland, T O Torbjorn Omland, T. OMLAND, T. Omland, Tobjørn Omland, Torbjoern Omland, Torbjøm Omland, TorbjĂ¸Rn Omland

Institutions: University of Oslo, Akershus University Hospital

Observed institutions: Oslo University Hospital, University of Oslo, Akershus University Hospital

OpenAlex ID: A5112709634

Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB)

2018 · Amy K. Saenger, Allan S. Jaffe, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 45

PDF

Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Bio-Markers

2019 · Peter A Kavsak, Carolyn S P Lam, et al. · Clinical Chemistry · 42

Sensitive cardiac troponin assays: sense and sensibility

2012 · T. Omland · European Heart Journal · 19

Establishing Reference Values in Healthy Participants for the Cardiac Troponin T High-Sensitivity Gen 6 Assay: REF-TSIX Global Reference Study

2026 · Lori B Daniels, Christian Mueller, et al. · Clinical Chemistry · 18

The relationship between early plasma atrial natriuretic factor levels and exercise performance after myocardial infarction

1993 · T. OMLAND, V. V. S. BONARJEE, et al. · European Heart Journal · 6

Clinical performance of the next generation Elecsys Troponin T high-sensitivity Gen 6 assay in acute coronary syndrome (PERFORM-TSIX): study design

2026 · Lori B. Daniels, Evangelos Giannitsis, et al. · Clinical Research in Cardiology · 3

PDF

A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk

2022 · Williams SA, Ostroff R, et al. · Yearbook of pediatric endocrinology · 3

Circulating secretoneurin concentrations provide independent prognostic information to established risk indices in patients with chronic heart failure

2022 · H Rosjo, J Meessen, et al. · European Heart Journal · 2

PDF

National Early Warning Score 2 provides independent prognostic information in patients hospitalized with heart failure with preserved ejection fraction

2022 · K Berge, J Brynildsen, et al. · European Heart Journal · 1

PDF

Biomarker-guided early heart failure assessment in hospitalized patients with tachypnea: results from the Akershus Cardiac Examination 4 Study

2026 · R Bhatnagar, K Lippestad, et al. · European Heart Journal

PDF

Impact of educational attainment on left atrial remodelling by sex: data from the Akershus Cardiac Examination (ACE) 1950 study

2026 · A O Bratholm, M G Solberg, et al. · European Heart Journal

PDF

Circulating secretoneurin concentrations predict cardiac arrythmia and mortality in patients with acute tachypnea: data from the akershus cardiac examination 4 study

2026 · M Lyngbakken, R Bhatnagar, et al. · European Heart Journal

PDF

Circulating secretoneurin concentrations predict mortality and heart failure hospitalizations but not ventricular arrhythmias in stable ICD outpatients

2026 · H Rosjo, P L Myhre, et al. · European Heart Journal

PDF

Circulating fragments of collagen I synthesis are associated with heart failure hospitalization and death two years after acute myocardial infarction in elderly patients

2026 · I Lunde, L Dahle, et al. · European Heart Journal

PDF

Effects of beta-blocker treatment on circulating biomarkers of fibrosis in patients with myocardial infarction without heart failure: A substudy of the BETAMI-DANBLOCK trial

2026 · I Lunde, L Dahle, et al. · European Heart Journal

PDF

Impact of point-of-care high-sensitivity troponin testing on index admission and 30-day costs: secondary analysis of a randomised controlled trial

2026 · I V L Thulin, S M F Jordalen, et al. · European Heart Journal

PDF

Cerebral hemodynamics in individuals with atrial fibrillation. Data from the ACE 1950 study cohort

2026 · H Ihle-Hansen, I N Nakstad, et al. · European Heart Journal

PDF

Agreement between manual and AI-enhanced echocardiographic assessment of cancer therapy-related cardiac dysfunction in patients with early breast cancer

2026 · E Orstad, P L Myhre, et al. · European Heart Journal

PDF

Cardioprotective effects of sacubitril/valsartan according to baseline cardiovascular risk during adjuvant breast cancer therapy: a randomized placebo-controlled trial

2026 · M N Gynnild, T Wethal, et al. · European Heart Journal

PDF

Physical inactivity measured by activity quotient score is associated with low cardiac volumes and mass and clinical events in middle-aged subjects from the general population

2026 · B T Risberg, A Vittersto, et al. · European Heart Journal

PDF

Incidence and severity of cancer-therapy-related cardiac dysfunction during contemporary breast cancer therapy in a real-world cohort

2026 · V Vinje, E B Orstad, et al. · European Heart Journal

PDF

Life’s Essential 8 and SCORE2 for cardiovascular risk prediction in a middle-aged general population: the Akershus Cardiac Examination 1950 Study

2026 · H Ihle-Hansen, A O B Bratholm, et al. · European Heart Journal

PDF

Global longitudinal strain and mechanical dispersion predict cardiovascular events in a middle-aged population: the ACE1950 study

2026 · C Koch, M N Lyngbakken, et al. · European Heart Journal

PDF

The effect of sacubitril/valsartan on functional disability and skeletal muscle injury during breast cancer therapy: insights from the PRADA II trial

2026 · V Vinje, M N Gynnild, et al. · European Heart Journal

PDF

Effects of sacubitril/valsartan on left and right ventricular function during and after breast cancer therapy: a randomised placebo-controlled trial

2026 · M N Gynnild, A Mecinaj-Lilleaasen, et al. · European Heart Journal

PDF

Works count: 51

Citation count: 139

H-index: 5

I10-index: 4